Astec LifeSciences Limited Financial Ratios
ASTEC · Chemicals · Current price ₹707.5
P/E ratio
-23.8x
P/B ratio
4.1x
ROE
-20.7%
ROCE
-5.5%
Debt / Equity
1.15
Dividend yield
0.2%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -23.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 4.1x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -20.7% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -5.5% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.15 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Astec LifeSciences Limited's latest numbers.
Astec LifeSciences Limited profitability
Astec LifeSciences Limited generates a return on equity of -20.7% and a return on capital employed of -5.5%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.15 and a P/E of -23.8x, Astec LifeSciences Limited is moderately leveraged. Our overall business-quality score for the company is 3.1 / 10.
Understand the ratios
More on Astec LifeSciences Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.